Seres Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Operational Progress Update

Go back to Seres Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Operational Progress Update
(NASDAQ: MCRB) Delayed: 6.60 -0.01 (0.15%)
Previous Close $6.61    52 Week High $44.51 
Open $6.68    52 Week Low $8.05 
Day High $7.05    P/E N/A 
Day Low $6.31    EPS $0.00 
Volume 81,636